in:
Share to Facebook Share to Twitter More...

13 Adverse Events Recorded on First Day of Sinovac Vaccination, According to Health Department

The Department of Health (DOH) recorded 13 adverse events during the first day of China’s Sinovac vaccine rollout.

On Tuesday (March 2, 2021), Health Undersecretary Maria Rosario Vergeire reported that several adverse events have been recorded on first day of administering the vaccine shots from China’s Sinovac.

Vergeire said that the events recorded were headache, nausea, pain at the injection site, itchiness, rashes and high-blood pressure. The health official is considering those incidents as minor events only.

Adverse Events

“All of them are common and all of them are minor adverse events, Wala sa kanilang na-admit, lahat sila ay inobserbahan, na-manage, at after a while they were all sent home,” Vergeire said.

The DOH undersecretary said that the government will be held accountable for adverse events following immunization because the vaccine shots are still under development. The manufacturer will have no liability in such incidents based on COVID-19 Vaccination Program Law signed by President Duterte.

Read Also: Malacañang Legal Team Studying if President Duterte Can Get Sinopharm Vaccine

Adverse Events

However, Vergeire said that the Health Department is satisfied with the result of vaccine rollout during the first day of implementation in the hospitals across Metro Manila. As of Monday (March 1), around 416 health workers got vaccinate.

What can you say about this incidents? Just feel free to leave your comments and reactions to this article.

Read Also: Health Secretary Duque Asks Health Workers to Get Vaccinated: ‘Huwag magduda’

Share to Facebook Share to Twitter More...

comment(s) for this post "DOH Records 13 Adverse Events on First Day of Sinovac Vaccination". Tell us what you think abut this post by leaving your comments below.

{ 0 comments… add one }

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.